GA Generic Assays GmbH, established in 2002 by Professor Dr. Dirk Roggenbuck, is an independent family company that focuses primarily on products for the differential diagnosis of autoimmune diseases. Hence, GA provide solutions to the challenges faced in this diagnostic field by ensuring optimal product quality and actively engaging in the development of innovative products in new relevant areas.

ZenTech is a biotechnology company specializing in the development and commercialization of In Vitro solutions and reagents. The tests are noninvasive and allow for neonatal screening as well as screening of rare, genetic, chronic or infectious metabolic diseases in human body fluid samples.